NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3034% below fair value
$10.71+0.02 (+0.19%)
Close on Nov 20, 2026Market cap $1.25BP/E –Yield –
NovoCure shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NovoCure's shares outstanding was 117M at Sep 30, 2026. For fiscal 2025 it was 111M, up 3.4% from the year before. Over ten years it grew 13.9% a year on average. The highest annual figure on record is 111M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 111M | +3.4% |
| FY2024 | Dec 31, 2024 | 108M | +1.4% |
| FY2023 | Dec 31, 2023 | 106M | +1.7% |
| FY2022 | Dec 31, 2022 | 105M | +1.2% |
| FY2021 | Dec 31, 2021 | 103M | -5.0% |
| FY2020 | Dec 31, 2020 | 109M | +12.0% |
| FY2019 | Dec 31, 2019 | 97M | +5.9% |
| FY2018 | Dec 31, 2018 | 92M | +3.7% |
| FY2017 | Dec 31, 2017 | 89M | +3.5% |
| FY2016 | Dec 31, 2016 | 86M | +181.4% |
| FY2015 | Dec 31, 2015 | 30M | +143.4% |
| FY2014 | Dec 31, 2014 | 12M | +8.6% |
| FY2013 | Dec 31, 2013 | 11M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 117M | +4.4% |
| Q2 FY2026 | Jun 30, 2026 | 116M | +4.0% |
| Q1 FY2026 | Mar 31, 2026 | 114M | +3.5% |
| Q4 FY2025 | Dec 31, 2025 | 112M | +3.5% |
| Q3 FY2025 | Sep 30, 2025 | 112M | +3.4% |
| Q2 FY2025 | Jun 30, 2025 | 112M | +3.6% |
| Q1 FY2025 | Mar 31, 2025 | 110M | +2.8% |
| Q4 FY2024 | Dec 31, 2024 | 108M | +1.3% |
| Q3 FY2024 | Sep 30, 2024 | 108M | +1.4% |
| Q2 FY2024 | Jun 30, 2024 | 108M | +1.3% |
| Q1 FY2024 | Mar 31, 2024 | 107M | +1.5% |
| Q4 FY2023 | Dec 31, 2023 | 107M | +1.8% |
| Q3 FY2023 | Sep 30, 2023 | 107M | +1.8% |
| Q2 FY2023 | Jun 30, 2023 | 106M | +1.6% |
| Q1 FY2023 | Mar 31, 2023 | 106M | +1.4% |
| Q4 FY2022 | Dec 31, 2022 | 105M | +1.1% |
| Q3 FY2022 | Sep 30, 2022 | 105M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | 105M | +1.1% |
| Q1 FY2022 | Mar 31, 2022 | 104M | +1.5% |
| Q4 FY2021 | Dec 31, 2021 | 104M | -6.1% |
| Q3 FY2021 | Sep 30, 2021 | 104M | -4.5% |
| Q2 FY2021 | Jun 30, 2021 | 103M | -3.9% |
| Q1 FY2021 | Mar 31, 2021 | 103M | -5.1% |
| Q4 FY2020 | Dec 31, 2020 | 111M | +2.5% |
| Q3 FY2020 | Sep 30, 2020 | 109M | +1.0% |
| Q2 FY2020 | Jun 30, 2020 | 108M | +11.7% |
| Q1 FY2020 | Mar 31, 2020 | 108M | +14.0% |
| Q4 FY2019 | Dec 31, 2019 | 108M | +15.9% |
| Q3 FY2019 | Sep 30, 2019 | 108M | +15.8% |
| Q2 FY2019 | Jun 30, 2019 | 96M | +5.5% |
| Q1 FY2019 | Mar 31, 2019 | 95M | +5.4% |
| Q4 FY2018 | Dec 31, 2018 | 93M | +4.1% |
| Q3 FY2018 | Sep 30, 2018 | 93M | +4.2% |
| Q2 FY2018 | Jun 30, 2018 | 91M | +3.5% |
| Q1 FY2018 | Mar 31, 2018 | 90M | +2.9% |
| Q4 FY2017 | Dec 31, 2017 | 89M | +3.0% |
| Q3 FY2017 | Sep 30, 2017 | 89M | – |
| Q2 FY2017 | Jun 30, 2017 | 88M | – |
| Q1 FY2017 | Mar 31, 2017 | 87M | – |
| Q4 FY2016 | Dec 31, 2016 | 87M | – |
See a number that looks wrong?